OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany
Anne Cossmann, Markus Hoffmann, Metodi V. Stankov, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 3, pp. e145-e146
Open Access | Times Cited: 6
Anne Cossmann, Markus Hoffmann, Metodi V. Stankov, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 3, pp. e145-e146
Open Access | Times Cited: 6
Showing 6 citing articles:
Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease
Karsten Lürken, Anna Meinecke, Luis A. Manthey, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Karsten Lürken, Anna Meinecke, Luis A. Manthey, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
EBioMedicine (2025) Vol. 113, pp. 105577-105577
Open Access
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
EBioMedicine (2025) Vol. 113, pp. 105577-105577
Open Access
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells
Joel Sop, A. Mercado, Alexis Figueroa, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Joel Sop, A. Mercado, Alexis Figueroa, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan
Kaori Sano, Takayuki Kurosawa, Kazuo HORIKAWA, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126452-126452
Closed Access | Times Cited: 1
Kaori Sano, Takayuki Kurosawa, Kazuo HORIKAWA, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126452-126452
Closed Access | Times Cited: 1
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial
David Griffin, Michael Dymock, Germaine Wong, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access
David Griffin, Michael Dymock, Germaine Wong, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
P. von der Schulenburg, Georg M. N. Behrens, Markus Hoffmann, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1942-1942
Open Access
P. von der Schulenburg, Georg M. N. Behrens, Markus Hoffmann, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1942-1942
Open Access
